ACC/AHA Guidelines Update for the Management of Patients With ST-Elevation Myocardial Infarction and Percutaneous Coronary Intervention (2009 STEMI and PCI Focused Updates). Do European guidelines need updating? – part I Review article
Article Sidebar
Published:
Apr 13, 2010
Keywords:
ACS, STEMI, PCI, guidelines
Main Article Content
Abstract
New clinical data in invasive cardiology encouraged ACC/AHA experts to revise an update Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction and Percutaneous Coronary Intervention (2009 STEMI and PCI Focused Updates). New guidelines apply modern therapies (new antiplatelet drugs) and technics in acute coronary syndromes. The role of invasive treatment in ACS is crucial and we still have new evidence for that.
Article Details
How to Cite
Chmielewski , M., & Janiszewski , M. (2010). ACC/AHA Guidelines Update for the Management of Patients With ST-Elevation Myocardial Infarction and Percutaneous Coronary Intervention (2009 STEMI and PCI Focused Updates). Do European guidelines need updating? – part I. Medycyna Faktow (J EBM), 3(1(6), 112-117. Retrieved from https://journalsmededu.pl/index.php/jebm/article/view/2623
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009; 120: 2271-2306.
2. Van’t Hof A.W., Ten Berg J., Heestermans T. et al.: Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, doubleblind, randomised controlled trial. Lancet 2008; 372: 537-46.
3. Stone G.W., Witzenbichler B., Guagliumi G. et al.: Bivalirudin during primary PCI in acute myocardial infarction. N. Engl. J. Med. 2008; 358: 2218-30.
4. Mehilli J., Kastrati A., Schulz S. et al.: Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial. Circulation 2009; 119: 1933-40.
5. Gurm H., Tamhane U., Meier P. et al.: A comparison of abciximab and small molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials. Circ. Cardiovasc. Intervent. 2009; 2: 230-6.
6. De Luca G., Ucci G., Cassetti E. et al.: Benefits from small molecule administration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-analysis. J. Am. Coll. Cardiol. 2009; 53: 1668-73.
7. Ellis S.G., Tendera M., de Belder M.A. et al.: Facilitated PCI in patients with ST-elevation myocardial infarction. N. Engl. J. Med. 2008; 358: 2205-17.
8. Wiviott S.D., Braunwald E., McCabe C.H. et al.: Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 2007; 357: 2001-15.
2. Van’t Hof A.W., Ten Berg J., Heestermans T. et al.: Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, doubleblind, randomised controlled trial. Lancet 2008; 372: 537-46.
3. Stone G.W., Witzenbichler B., Guagliumi G. et al.: Bivalirudin during primary PCI in acute myocardial infarction. N. Engl. J. Med. 2008; 358: 2218-30.
4. Mehilli J., Kastrati A., Schulz S. et al.: Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial. Circulation 2009; 119: 1933-40.
5. Gurm H., Tamhane U., Meier P. et al.: A comparison of abciximab and small molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials. Circ. Cardiovasc. Intervent. 2009; 2: 230-6.
6. De Luca G., Ucci G., Cassetti E. et al.: Benefits from small molecule administration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-analysis. J. Am. Coll. Cardiol. 2009; 53: 1668-73.
7. Ellis S.G., Tendera M., de Belder M.A. et al.: Facilitated PCI in patients with ST-elevation myocardial infarction. N. Engl. J. Med. 2008; 358: 2205-17.
8. Wiviott S.D., Braunwald E., McCabe C.H. et al.: Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 2007; 357: 2001-15.